https://timesbeats.com/press-releases/lillys-foundayo-orforglipron-significantly-reduced-obstructive-sleep-apnea-severityTimes Beatsen2026-11-09T14:42:33.046ZLilly's Foundayo (orforglipron) significantly reduced obstructive sleep apnea severity, reinforcing its potential to improve health beyond weight loss https://timesbeats.com/press-releases/onemednet-reports-dollar1876-million-in-year-to-date-of-contracted-bookings-and-publishesTimes Beatsen2026-11-09T13:55:37.150ZOneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap https://timesbeats.com/press-releases/silexion-therapeutics-announces-1-for-24-reverse-share-splitTimes Beatsen2026-11-09T12:31:10.644ZSilexion Therapeutics Announces 1-for-24 Reverse Share Split https://timesbeats.com/press-releases/glyconex-announces-japanese-regulatory-submission-for-denosumab-biosimilar-spd8Times Beatsen2026-11-09T01:12:26.890ZGlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8 https://timesbeats.com/press-releases/antengene-presents-latest-preclinical-results-of-novel-cos-tce-platform-antengagerd2-inTimes Beatsen2026-11-09T00:34:29.097ZAntengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026 https://timesbeats.com/press-releases/innovent-announces-phase-3-credit-5-study-met-primary-endpoint-sintbilor-tafolecimabTimes Beatsen2026-11-09T00:25:41.775ZInnovent Announces Phase 3 CREDIT-5 Study Met Primary Endpoint, SINTBILO® (Tafolecimab Injection) as First-line Monotherapy Treatment for Hyperlipidemia Demonstrated Potent Lipid-lowering Efficacy https://timesbeats.com/roundups/entertainment-media-and-sports-week-of-nov-2-2026Times Beatsen2026-11-09T09:32:00.000Z https://timesbeats.com/roundups/food-beverage-and-agriculture-week-of-nov-2-2026Times Beatsen2026-11-09T08:48:00.000ZKFC's partners and parent dominate: the week in food and agriculture https://timesbeats.com/roundups/retail-and-consumer-week-of-nov-2-2026Times Beatsen2026-11-09T08:37:00.000ZEarnings and guidance resets lead the week in consumer releases https://timesbeats.com/roundups/environment-and-sustainability-week-of-nov-2-2026Times Beatsen2026-11-09T07:53:00.000ZEthanol deal and plastic alternatives: the week in sustainability https://timesbeats.com/roundups/real-estate-and-construction-week-of-nov-2-2026Times Beatsen2026-11-09T07:53:00.000ZTariff refunds, a housing pullback and condo contracts: the week https://timesbeats.com/roundups/government-and-policy-week-of-nov-2-2026Times Beatsen2026-11-09T07:42:00.000ZDOJ steps up fraud and election cases: the week in policy releases https://timesbeats.com/roundups/manufacturing-and-industrial-week-of-nov-2-2026Times Beatsen2026-11-09T07:42:00.000ZQ3 results and portfolio reshaping: the week in manufacturing https://timesbeats.com/roundups/marketing-week-of-nov-2-2026Times Beatsen2026-11-09T07:31:00.000ZVertical agencies and AI tools: the week in marketing releases https://timesbeats.com/roundups/business-week-of-nov-2-2026Times Beatsen2026-11-09T07:20:00.000ZGuidance raises and telecom cost cuts: the week in Q3 earnings https://timesbeats.com/roundups/earnings-and-investor-news-week-of-nov-2-2026Times Beatsen2026-11-09T07:20:00.000ZDeals reshape quarterly results: the week in earnings https://timesbeats.com/roundups/finance-and-banking-week-of-nov-2-2026Times Beatsen2026-11-09T07:09:00.000ZEarnings, tokenized repo and new options: the week in finance https://timesbeats.com/roundups/biotech-and-pharma-week-of-nov-2-2026Times Beatsen2026-11-09T07:09:00.000ZQ3 results reshape biotech pipelines: the week in Biotech & Pharma https://timesbeats.com/roundups/health-and-medical-week-of-nov-2-2026Times Beatsen2026-11-09T06:58:00.000ZCVS split leads a week of health portfolio reshaping https://timesbeats.com/roundups/travel-and-hospitality-week-of-nov-2-2026Times Beatsen2026-11-09T06:58:00.000ZQ3 earnings and a casino strike settlement: the week in travel https://timesbeats.com/roundups/mining-and-metals-week-of-nov-2-2026Times Beatsen2026-11-09T06:58:00.000ZQ3 earnings and U.S. gold exploration: the week in mining https://timesbeats.com/roundups/energy-and-utilities-week-of-nov-2-2026Times Beatsen2026-11-09T06:58:00.000ZQ3 earnings bring buybacks and restructurings: the week in energy https://timesbeats.com/roundups/crypto-and-blockchain-week-of-nov-2-2026Times Beatsen2026-11-09T06:58:00.000ZTokenized markets grow, AI and crypto overlap: the week in crypto